Acquisition of Opalia Pharma

2013 - 2013

Our attorneys advised Recordati, a pharmaceutical company based in Milan, Italy, in its acquisition of the majority of Opalia Pharma S.A., a Tunisian pharmaceutical company with headquarters in Ariana, a suburb of Tunis for TND 80 million (around € 37 million). Our attorneys led on the sale documents for this deal, a matter that involved cross border coordination within its European life sciences practice.

Email Disclaimer